Vaccination for Cluster Headache involves administering antibodies or immunomodulatory agents that target specific inflammatory pathways and neuropeptides involved in headache pathogenesis. The primary mechanism focuses on reducing CGRP (calcitonin gene-related peptide) levels and modulating neurogenic inflammation, which can decrease the frequency and intensity of cluster headache episodes by interrupting pain signal transmission and neuroinflammatory processes.